Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Endorex Corporation (AMEX:DOR)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | SEC | Msgs | Insider
Location
28101 Ballard Drive, Suite F
Lake Forest, IL 60045
Phone: (847) 573-8990
Fax: (847) 573-9285
Email: theproteam@aol.com
Employees (last reported count): 18
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Websites
 ·Home Page
 ·Investor Relations
 ·Products & Services
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 63%
·Institutional: 33% (90% of float)
(6 institutions)
·Net Inst. Buying: 23.0K shares (+0.54%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Endorex Corporation is a development stage, drug delivery company. The Company's core drug delivery technology focuses on oral/mucosal delivery of drugs and vaccines previously delivered only by injection. The Company's Orasome system utilizes technology licensed from Massachusetts Institute of Technology to develop the oral/mucosal delivery of vaccines, proteins and peptides. In 1998 the Company formed two joint ventures with Elan Corporation, plc, one of the world's leading drug delivery companies. The purpose of the first joint venture, InnoVaccines Corporation, is to research, develop, and commercialize novel delivery systems for the human and veterinary vaccine markets. The second joint venture, Endorex Newco, LTD., focuses on the utilization of the MEDIPAD microinfusion pump, developed by Elan, to deliver iron chelators for the treatment of a series of genetic blood disorders known as iron overload disorders.
More from Market Guide: Expanded Business Description

Financial Summary
Endorex Corporation is a development stage bio-technology company involved in oral drug delivery and cancer therapy. The Company has developed two products which have undergone clinical trials. For the six months ended 6/30/01, the Company reported no revenues. Net loss applicable to Common fell 8% to $3.1 million. Lower loss reflects an overall decrease in joint venture R&D activities as the Company redirected its drug delivery research focus.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY1999 Pay

Kenneth Tempero, M.D., Ph.D., 60
Chairman
--  
Michael Rosen, 47
Pres, CEO
$269K
Frank Reid, 50
VP of Fin. and Corp. Devel.
--  
Panayiotis Constantinides, Ph.D.
VP-R&D
--  
John McCracken
VP-Bus. Devel.
--  
Dollar amounts are as of 31-Dec-1999 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- AMEX:DORAs of 31-Aug-2001
Price and Volume
52-Week Low
on 25-Apr-2001
$0.75 
Recent Price$1.00 
52-Week High
on 11-Sep-2000
$2.875
Beta-0.59 
Daily Volume (3-month avg)8,000 
Daily Volume (10-day avg)5,000 
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change-56.8%
52-Week Change
relative to S&P500
-42.0%
Share-Related Items
Market Capitalization$12.7M
Shares Outstanding12.7M
Float4.70M
Dividends & Splits
Annual Dividendnone 
Last Split: 1 for 15 on 11-June-1997
Per-Share Data
Book Value (mrq)-$0.96 
Earnings (ttm)-$0.46 
Earnings (mrq)-$0.12 
SalesN/A 
Cash (mrq)$0.77 
Valuation Ratios
Price/BookN/A 
Price/EarningsN/A 
Price/SalesN/A 
Income Statements
Sales (ttm)$0 
EBITDA (ttm)-$3.69M
Income available to common (ttm)-$5.89M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-33.21%
Return on EquityN/A 
Financial Strength
Current Ratio (mrq)3.03 
Debt/Equity (mrq)0.04 
Total Cash (mrq)$9.81M
Short Interest
As of 9-July-2001
Shares Short0 
Shares Short
(Prior Month)
0 
Daily Volume5,000 
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.